,49 Taken together, our data suggest that dysregulated expression of PPBP through DNA methylation alterations provides a protumor survival advantage for AFR patients with CRC, and further studies are warranted to ascertain their precise role in CRC pathogenesis. The gene discussed is PPBP; the disease is colorectal carcinoma.